Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc.verified

PIRS

Price:

$16.4849

Market Cap:

$21.76M

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate that is in Phase II clinical trial targeting IL-4Ra for the treatment of asthma and other inflammatory diseases; PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis; ...[Read more]

Industry

Biotechnology

IPO Date

2015-01-02

Stock Exchange

NASDAQ

Ticker

PIRS

The Dividend Yield as of September 2024 (TTM) for Pieris Pharmaceuticals, Inc. (PIRS) is 0%

According to Pieris Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Pieris Pharmaceuticals, Inc. (PIRS) Historical Dividend Yield (quarterly & annually)

How has PIRS Dividend Yield performed in the past?

The mean historical Dividend Yield of Pieris Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PIRS's Dividend Yield was at its highest in in the September 2014 quarter at 0%. The Dividend Yield was at its lowest in in the September 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Pieris Pharmaceuticals, Inc. (PIRS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Pieris Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Pieris Pharmaceuticals, Inc. (PIRS) Average Dividend Yield

How has PIRS Dividend Yield performed in the past?

The current Dividend Yield of Pieris Pharmaceuticals, Inc. (PIRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Pieris Pharmaceuticals, Inc. (PIRS) Dividend Yield vs. Peers

How is PIRS’s Dividend Yield compared to its peers?

Pieris Pharmaceuticals, Inc.’s Dividend Yield is less than Adaptimmune Therapeutics plc (0%), less than Mereo BioPharma Group plc (0%), less than PDS Biotechnology Corporation (0%), less than Leap Therapeutics, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Corvus Pharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than TCR2 Therapeutics Inc. (0%), less than Affimed N.V. (0%), less than ADC Therapeutics SA (0%), less than Agenus Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Achilles Therapeutics plc (0%), less than Checkpoint Therapeutics, Inc. (0%), less than Cue Biopharma, Inc. (0%), less than Medicenna Therapeutics Corp. (0%),

Build a custom stock screener for Pieris Pharmaceuticals, Inc. (PIRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pieris Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pieris Pharmaceuticals, Inc. (PIRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pieris Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Pieris Pharmaceuticals, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Pieris Pharmaceuticals, Inc. (PIRS)?

What is the highest Dividend Yield for Pieris Pharmaceuticals, Inc. (PIRS)?

What is the 3-year average Dividend Yield for Pieris Pharmaceuticals, Inc. (PIRS)?

What is the 5-year average Dividend Yield for Pieris Pharmaceuticals, Inc. (PIRS)?

How does the current Dividend Yield for Pieris Pharmaceuticals, Inc. (PIRS) compare to its historical average?